This vignette highlights the ethical issues surrounding restricted access to oncology drugs caused by drug shortages. A review of selected literature and a framework for creating institutional guidelines for reacting to shortage is provided.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595447 | PMC |
http://dx.doi.org/10.1200/JOP.2012.000779 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!